News | Radiology Business | September 07, 2022

Accuray will anchor hub that will unite companies from the MedTech, pharma and biosciences sectors, physicians and scientists 

Accuray Will Anchor Hub That Will Unite Companies From the MedTech, Pharma and Biosciences Sectors, Physicians and Scientists

September 7, 2022 — Accuray Incorporated announced the company is joining forces with Genolier Innovation Hub, a fully-owned subsidiary of AEVIS VICTORIA SA, in support of a unique new approach to improving patient care. Genolier Innovation Hub will unite companies from the medtech, pharma and biosciences sectors, physicians and scientists, under one roof, with the goal of bringing medical and technological advances to patients faster. The Hub is expected to open in early 2024. 

Genolier Innovation Hub will be located in the heart of the Genolier Healthcare Campus in Genolier, Switzerland. The facility will offer different workspaces to meet the varied requirements of the participants including operating rooms to support simulation-based training, bunkers with radiation therapy systems for training, R&D and demonstration, and meeting rooms equipped with the most advanced technologies to host seminars, workshops and events. Accuray will leverage the Hub as a global training center where customers will have the opportunity to obtain hands-on training and learn about advanced radiation therapy techniques – using its CyberKnife and Radixact Systems – from renowned faculty. 

The CyberKnife and Radixact Systems are radiation therapy devices that have been proven to deliver highly effective treatments for a broad range of tumors almost anywhere in the body. The systems include advanced functionality that make it easier and more efficient to administer extremely precise radiation treatments, even to targets that move, providing the medical care team with options for managing the full spectrum of cancer cases, from routine to complex and initial treatment to retreatment, and neurologic disorders. The two systems are successfully being used at the Clinique Générale-Beaulieu in Geneva, and the Radixact System will also be used at the Clinique de Genolier, both being flagship clinics of the Swiss Medical Network, AEVIS’s main shareholding. 

“We are proud to lead the radiation therapy industry as an anchor for Genolier Innovation Hub. Our involvement is consistent with our focus on advancing patient care through investments in innovation in all aspects of our business, from our technology to clinical support and education,” said Suzanne Winter, president and chief executive officer of Accuray. “We look forward to partnering with Genolier Innovation Hub to usher in a new level of collaboration that speeds the progress made in patient-centric care. This is a long-term commitment for both companies.” 

“Our philosophy is to put the patient at the heart of everything we do. This viewpoint is a key driver behind the new Genolier Innovation Hub which is designed to provide a forum for creating cross-sector relationships that drive unprecedented improvements in care,” said Antoine Hubert, Chairman of the Board of Genolier Innovation Hub and Delegate of the Board of Directors of AEVIS Victoria SA. “Accuray shares our vision and I am confident that by working together we can create a model that sets a new standard in the healthcare industry.” 

For more information: www.accuray.com 


Related Content

News | ASTRO

The 64th Annual Meeting of the American Society for Radiation Oncology (ASTRO) will take place October 23-26, at the ...

Time September 29, 2022
arrow
Feature | Radiology Imaging

View the September/October digital edition of Imaging Technology News (ITN), including links to videos, comparison ...

Time September 29, 2022
arrow
News | Radiation Therapy

September 29, 2022 — Radformation Inc and Videra Surgical are pleased to announce a collaboration integrating Videra ...

Time September 29, 2022
arrow
News | PET Imaging

September 28, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time September 28, 2022
arrow
News | PET-CT

September 28, 2022 — Xoran Technologies is engaged in a ground-breaking research project to develop a PET/CT scanner for ...

Time September 28, 2022
arrow
News | Enterprise Imaging

September 27, 2022 — Intelerad Medical Systems, a leading global provider of enterprise imaging solutions, announced its ...

Time September 27, 2022
arrow
News | Radiation Oncology

September 26, 2022 — Cleveland Clinic received a $7.9 million five-year grant from the National Cancer Institute at the ...

Time September 26, 2022
arrow
News | Radiopharmaceuticals and Tracers

September 22, 2022 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time September 22, 2022
arrow
News | Contrast Media

Editor’s note: On September 21, 2022, both Guerbet and Bracco Diagnostics released news detailing the FDA approval of a ...

Time September 22, 2022
arrow
News | Digital Pathology

September 22, 2022 — By partnering with Hamamatsu, Infinitt can offer an enhanced integration with NanoZoomers, enabling ...

Time September 22, 2022
arrow
Subscribe Now